am i eligible for glp 1 GLP-1 Medications Infographic Which GLP-1 Is Right for

Contact Skippack Pharmacy if: Your provider has already sent your prescription

Wegovy was approved by the United States FDA in June 2021 for the management of obesity

Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure

[4] Whilst these incretin-based therapies offer significant metabolic benefits, they commonly affect gastrointestinal function, including bowel movements

In available GLP-1 tablet clinical data, pancreatitis was uncommon, generally reported at well below 1% of patients or as a small number of cases per 100 patient-years

Lower insulin requirements are also noted in real-world studies (50, 51)